DLP-118

N/A

Report date: 2025/01/26 19:12:40
NME

Base Information

Drug NameDLP-118
Drug Alias Namepaliperidone (Delpor)DLP-118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDelpor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDelpor Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaBipolar Disorder

Other Information

ATC CodeN/A
Related LinksN/A